Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason P Connor

Showing results (81-90 of 171) with videos related to

Pageof 18
Sort By:
Drug and Alcohol Review|May 26, 2017
Validation of the Adolescent Drinking Expectancy Questionnaire and development of a short formKiri A Patton, Jason P Connor, Sharyn Rundle-Thiele, et al.
Pain|October 21, 2020
Impact of a policy change restricting access to codeine on prescription opioid-related emergency department presentations: an interrupted time series analysisRachel A Elphinston, Jason P Connor, Dominique de Andrade, et al.
American Journal of Preventive Medicine|July 1, 2025
Adolescent Cannabis Vaping Trends (2021-2023): Delta-9-Tetrahydrocannabinol, Cannabidiol, and Synthetic CannabinoidsJack Chung, Carmen C W Lim, Daniel Stjepanović, et al.
Drug and Alcohol Review|December 13, 2023
Participation in Australian drug treatment programs for individuals engaging in high-risk substance use: Data from a nationally representative sampleJanni Leung, Tesfa Mekonen Yimer, Vivian Chiu, et al.
Drug and Alcohol Review|March 2, 2011
The influence of parents, siblings and peers on pre- and early-teen smoking: a multilevel modelAdrian B Kelly, Martin O'Flaherty, Jason P Connor, et al.
Addictive Behaviors|June 13, 2006
Heavy nicotine and alcohol use in alcohol dependence is associated with D2 dopamine receptor (DRD2) polymorphismJason P Connor, Ross McD Young, Bruce R Lawford, et al.
Addictive Behaviors|May 17, 2020
Multiple opioid prescribers: A genuine quest for treatment rather than aberrant behaviour. A two-decade population-based studyAdeleke D Adewumi, Joemer C Maravilla, Rosa Alati, et al.
Journal of Psychiatry & Neuroscience : JPN|February 24, 2006
Does naltrexone treatment lead to depression? Findings from a randomized controlled trial in subjects with opioid dependenceAngela J Dean, John B Saunders, Rod T Jones, et al.
The Australian and New Zealand Journal of Psychiatry|May 18, 2017
Prevalence and correlates of bullying victimisation and perpetration in a nationally representative sample of Australian youthHannah J Thomas, Jason P Connor, David M Lawrence, et al.
International Journal of Clinical Pharmacy|September 23, 2020
Pharmaceutical opioids utilisation by dose, formulation, and socioeconomic status in Queensland, Australia: a population study over 22 yearsAdeleke D Adewumi, Joemer C Maravilla, Rosa Alati, et al.
Pageof 18

Showing results (81-90 of 171) with videos related to

Sort By:
Pageof 18
Drug and Alcohol Review|May 26, 2017
Validation of the Adolescent Drinking Expectancy Questionnaire and development of a short formKiri A Patton, Jason P Connor, Sharyn Rundle-Thiele, et al.
Pain|October 21, 2020
Impact of a policy change restricting access to codeine on prescription opioid-related emergency department presentations: an interrupted time series analysisRachel A Elphinston, Jason P Connor, Dominique de Andrade, et al.
American Journal of Preventive Medicine|July 1, 2025
Adolescent Cannabis Vaping Trends (2021-2023): Delta-9-Tetrahydrocannabinol, Cannabidiol, and Synthetic CannabinoidsJack Chung, Carmen C W Lim, Daniel Stjepanović, et al.
Drug and Alcohol Review|December 13, 2023
Participation in Australian drug treatment programs for individuals engaging in high-risk substance use: Data from a nationally representative sampleJanni Leung, Tesfa Mekonen Yimer, Vivian Chiu, et al.
Drug and Alcohol Review|March 2, 2011
The influence of parents, siblings and peers on pre- and early-teen smoking: a multilevel modelAdrian B Kelly, Martin O'Flaherty, Jason P Connor, et al.
Addictive Behaviors|June 13, 2006
Heavy nicotine and alcohol use in alcohol dependence is associated with D2 dopamine receptor (DRD2) polymorphismJason P Connor, Ross McD Young, Bruce R Lawford, et al.
Addictive Behaviors|May 17, 2020
Multiple opioid prescribers: A genuine quest for treatment rather than aberrant behaviour. A two-decade population-based studyAdeleke D Adewumi, Joemer C Maravilla, Rosa Alati, et al.
Journal of Psychiatry & Neuroscience : JPN|February 24, 2006
Does naltrexone treatment lead to depression? Findings from a randomized controlled trial in subjects with opioid dependenceAngela J Dean, John B Saunders, Rod T Jones, et al.
The Australian and New Zealand Journal of Psychiatry|May 18, 2017
Prevalence and correlates of bullying victimisation and perpetration in a nationally representative sample of Australian youthHannah J Thomas, Jason P Connor, David M Lawrence, et al.
International Journal of Clinical Pharmacy|September 23, 2020
Pharmaceutical opioids utilisation by dose, formulation, and socioeconomic status in Queensland, Australia: a population study over 22 yearsAdeleke D Adewumi, Joemer C Maravilla, Rosa Alati, et al.
Pageof 18